Azenta (NASDAQ:AZTA – Get Free Report) released its quarterly earnings results on Monday. The company reported $0.13 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.12, Briefing.com reports. Azenta had a negative net margin of 2.14% and a positive return on equity of 0.73%. The business had revenue of $165.95 million for the quarter, compared to analyst estimates of $163.91 million. During the same period last year, the firm earned $0.16 earnings per share. Azenta’s revenue for the quarter was up 25.0% compared to the same quarter last year. Azenta updated its FY 2024 guidance to $0.19-$0.29 EPS.
Azenta Stock Performance
Shares of AZTA stock opened at $54.45 on Wednesday. The firm has a fifty day simple moving average of $49.49 and a two-hundred day simple moving average of $47.97. Azenta has a 12 month low of $36.01 and a 12 month high of $63.60.
Hedge Funds Weigh In On Azenta
A number of hedge funds have recently bought and sold shares of the company. Virginia Retirement Systems ET AL purchased a new position in Azenta during the 2nd quarter worth $257,000. IMA Wealth Inc. boosted its holdings in shares of Azenta by 0.6% in the 2nd quarter. IMA Wealth Inc. now owns 39,535 shares of the company’s stock worth $1,845,000 after buying an additional 232 shares during the last quarter. State of Tennessee Treasury Department boosted its holdings in shares of Azenta by 100.6% in the 2nd quarter. State of Tennessee Treasury Department now owns 37,654 shares of the company’s stock worth $1,758,000 after buying an additional 18,880 shares during the last quarter. Natixis Advisors L.P. boosted its holdings in shares of Azenta by 4.6% in the 2nd quarter. Natixis Advisors L.P. now owns 447,249 shares of the company’s stock worth $20,878,000 after buying an additional 19,594 shares during the last quarter. Finally, Integrated Wealth Concepts LLC purchased a new position in shares of Azenta in the 2nd quarter worth about $772,000. 99.08% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Azenta, Inc provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.
- Five stocks we like better than Azenta
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- The only 2 cannabis companies you need to own
- How to Buy Cheap Stocks Step by Step
- Is it time to buy EVOLV Technologies after post-earnings dip?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Even at a 2-year high, DraftKings is a winning bet
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.